Array Biopharma Inc (ARRY)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

3200 WALNUT STREET BOULDER, CO 80301

Operates as a biopharmaceutical company that focuses on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Its proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease.

Data based on most recent fiscal year report
Market Cap3.032 Billion Shares Outstanding197.03 Million Avg Volume6.003 Million
1-Yr BETA vs S&P TR Current Ratio3.88 Quick Ratio3.88
View SEC Filings from ARRY instead.
Q1 2019 All Institutions Hedge Funds 1
To trade ARRY now:
Filers who had this stock in their top 10: 12 7 (0.71%)
13F Filers holding this stock: 263 49 (4.99%)
Aggregate 13F shares on 03/31/2019: 222.163 Million 50.186 Million
Aggregate 13F shares on 12/31/2018: 213.67 Million 50.073 Million
Percent change: 3.97% 0.22%
Funds creating new positions: 61 14
Funds Adding to an existing position: 101 14
Funds closing out their position: 28 10
Funds reducing their position: 73 18
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARRY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

267.4 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

239.3 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

REDMILE GROUP, LLC

GREEN JEREMY

  • Director
0 2019-06-30 0

KOCH KEVIN

  • Director
0 2019-06-19 0

ORWIN JOHN A PRESIDENT & CEO

  • Officer
  • Director
0 2019-06-19 1

SHARP SHALINI

  • Director
0 2019-06-17 1

RATCLIFFE LIAM

  • Director
0 2019-06-14 0

BAUM CHARLES M

  • Director
9,667 2019-06-07 1

WILLIAMS DOUGLAS E

  • Director
0 2019-06-07 0

COX CARRIE SMITH

  • Director
0 2019-06-07 5

SANDOR VICTOR CHIEF MEDICAL OFFICER

209,543 2019-06-04 9

SQUARER RON

  • Director
8,875 2019-05-08 4

ROBBINS ANDREW R COO

71,022 2019-04-01 3

SACCOMANO NICHOLAS A CSO

150,190 2019-04-01 4

VAN LUNSEN GIL J

  • Director
27,531 2019-03-01 3

LEFKOFF KYLE

57,720 2019-02-06 2

NEEDLE MICHAEL N CHIEF MEDICAL OFFICER

  • Officer
0 2019-02-06 0

HADDOCK JASON CFO

30,059 2019-02-06 4

OLTMANS CURTIS GALE GENERAL COUNSEL

15,021 2019-01-29 5

CONWAY ROBERT E

  • Director
0 2019-01-02 0

FYFE GWEN A.

15,000 2018-10-25 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2017-07-14 0

MOORE JOHN R VP, GENERAL COUNSEL

40,102 2017-04-01 0

HORIN DAVID J INTERIM CFO

  • Officer
0 2016-09-26 0

HENAHAN MARY P. CHIEF FINANCIAL OFFICER

0 2015-09-08 0

SNITMAN DAVID COO AND VP, BUSINESS DEVEL.

  • Officer
7,477 2015-03-01 0

CARRUTHERS MICHAEL CFO

  • Officer
0 2014-08-18 0

ZABRISKIE JOHN L

  • Director
49,748 2013-11-14 0

BULLOCK FRANCIS J

  • Director
0 2011-10-26 0

CARUTHERS MARVIN H

  • Director
446,934 2011-08-16 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-06-04 M 100,000 d 87,500 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-06-04 S 100,000 $28.51 d 209,543 209,543.00 direct yes

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-06-04 M 100,000 $7.30 a 309,543 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-06-03 M 36,134 d 0 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-06-03 M 36,134 $3.65 a 245,677 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-06-03 S 36,134 $27.58 d 209,543 209,543.00 direct yes

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-30 M 15,728 d 36,134 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-30 S 15,728 $27.50 d 209,543 209,543.00 direct yes

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-30 M 15,728 $3.65 a 225,271 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-28 M 46,766 d 51,862 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-28 M 46,766 $3.65 a 284,458 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-28 S 74,915 $27.00 d 209,543 209,543.00 direct yes

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-23 M 40,634 $3.65 a 278,326 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-23 M 40,634 d 98,628 209,543.00 direct

SANDOR VICTOR CHIEF MEDICAL OFFICER

2019-05-23 S 40,634 $26.50 d 237,692 209,543.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments